Surmodics (NASDAQ:SRDX) reported quarterly losses of $(0.17) per share which met the analyst consensus estimate. This is a 180.95 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $23.87 million which beat the analyst consensus estimate of $23.31 million by 2.42 percent. This is a 11.20 percent decrease over sales of $26.88 million the same period last year.
Surmodics Q3 EPS $(0.17), Inline, Sales $23.87M Beat $23.31M Estimate
Surmodics (NASDAQ:SRDX) reported quarterly losses of $(0.17) per share which met the analyst consensus estimate. This is a 180.95 percent decrease over earnings of $0.21 per share from the same period last year. The
